
LBA47Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC
Kaseb, A, Duda, D G, Tran Cao, H S, Abugabal, Y I, Vence, L M, Rashid, A, Carmagnani Pestana, R, Blando, J M, Singh, S, Vauthey, J N, Chun, Y S, Tzeng, C-W D, Sakamuri, D, Wolff, R A, Yao, J C, AllisoVolume:
30
Langue:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz394.038
Date:
October, 2019
Fichier:
PDF, 69 KB
english, 2019